All Stories

  1. The Asian Thyroid Working Group, from 2017 to 2023
  2. The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis
  3. De novo versus secondary dedifferentiated chordomas: a population-based analysis and integrated individual participant data meta-analysis
  4. Primary versus secondary gliosarcoma: a systematic review and meta-analysis
  5. Clinical detection of “extremely low‐risk” follicular thyroid carcinoma: A population‐based study of 7304 patients
  6. The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age
  7. Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas
  8. Chondrosarcoma and chordoma of the skull base and spine: implication of tumor location on patient survival
  9. The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas
  10. The differences in distant metastatic patterns and their corresponding survival between thyroid cancer subtypes
  11. Incidence, Prognostic Factors, and Survival Trend in Pineal Gland Tumors: A Population-Based Analysis
  12. H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients
  13. Long‐term outcomes of primary cardiac malignant tumors: Difference between African American and Caucasian population
  14. H3K27M-mutant Diffuse Midline Gliomas should be Further Molecularly Stratified: An Integrated Analysis of 669 Patients
  15. Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study
  16. Primary Versus Secondary Anaplastic Thyroid Carcinoma: Perspectives from Multi-institutional and Population-Level Data
  17. Response to Cherella et al. re: “The Use of the Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: A Meta-Analysis”
  18. The Differences in Distant Metastatic Patterns and Their Corresponding Survival Between Thyroid Cancer Subtypes
  19. The Incidence of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Meta-Analysis Assessing Worldwide Impact of the Reclassification
  20. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis
  21. Malignant thyroid teratoma: an integrated analysis of case series/case reports
  22. Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past Two Decades: A Population-based Study
  23. Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta‐analysis
  24. Incidence, Risk Factors, and Prognosis of Meningiomas With Distant Metastases at Presentation
  25. Consolidating the Hyams grading system in esthesioneuroblastoma – an individual participant data meta-analysis
  26. The Use of the Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: A Meta-Analysis
  27. Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentation
  28. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Pediatric Population
  29. Risk factors for tumor recurrence and progression of spindle cell oncocytoma of the pituitary gland: a systematic review and pooled analysis
  30. Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations
  31. Genetic differences in follicular thyroid carcinoma between Asian and Western countries: a systematic review
  32. The diversities in thyroid cytopathology practices among Asian countries using the Bethesda system for reporting thyroid cytopathology
  33. The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
  34. The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
  35. Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis
  36. Impact of Molecular Testing on the Management of Indeterminate Thyroid Nodules Among Western and Asian Countries: a Systematic Review and Meta-analysis
  37. Diagnostic performances of the Afirma Gene Sequencing Classifier in comparison with the Gene Expression Classifier: A meta‐analysis
  38. The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
  39. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta‐analysis
  40. Assessment of peritoneal elastic laminal invasion improves survival stratification of pT3 and pT4a colorectal cancer: a meta-analysis
  41. Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta‐analysis
  42. CLINICAL IMPACT OF NON-INVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES ON THE RISK OF MALIGNANCY IN THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A META-ANALYSIS OF 14,153 RESECTED THYROID NODULES
  43. Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
  44. Prognostic significance of genetic biomarkers in isocitrate dehydrogenase-wild-type lower-grade glioma: the need to further stratify this tumor entity - a meta-analysis
  45. Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer – A systematic review and meta-analysis
  46. High expression of CD10 in anaplastic thyroid carcinomas
  47. Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis
  48. Prognostic importance of solid variant papillary thyroid carcinoma: A systematic review and meta-analysis
  49. TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups—A meta-analysis of aggregate data
  50. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations—a meta-analysis
  51. Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis
  52. Paediatric follicular thyroid carcinoma - indolent cancer with low prevalence of RAS mutations and absence of PAX8-PPARG fusion in a Japanese population
  53. Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis
  54. Prognostic impact of vascular invasion in differentiated thyroid carcinoma: a systematic review and meta-analysis
  55. BRAF Mutation is Associated with an Improved Survival in Glioma—a Systematic Review and Meta-analysis
  56. A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma
  57. Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis
  58. Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complex
  59. Immunohistochemical detection of NRASQ61R protein in follicular-patterned thyroid tumors
  60. Thyroid cancer and iodine intake
  61. Spindle cell oncocytoma of adenohypophysis: Report of a case and immunohistochemical review of literature
  62. The changing characteristics and molecular profiles of papillary thyroid carcinoma over time - a systematic review